Phar Vision Advisers, LLC Treace Medical Concepts, Inc. Transaction History
Phar Vision Advisers, LLC
- $118 Billion
- Q4 2024
A detailed history of Phar Vision Advisers, LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 19,246 shares of TMCI stock, worth $193,422. This represents 0.12% of its overall portfolio holdings.
Number of Shares
19,246Holding current value
$193,422% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding TMCI
# of Institutions
138Shares Held
38.1MCall Options Held
52KPut Options Held
19.1K-
Armistice Capital, LLC New York, NY6.21MShares$62.4 Million0.65% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$40.9 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.94MShares$29.5 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$27.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.14MShares$21.5 Million0.0% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $557M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...